Arkolith/Insider Trading/RCKT/Form 4

RTW Investments, LP

Director, 10% OwnerROCKET PHARMACEUTICALS, INC. (RCKT) · full profile →Form 4 · filed Sep 23, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
9
6 non-derivative · 3 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Sep 19, 2025Option exercise(X)1.0M$40.03—19.2M
Sep 19, 2025Other(J)1.0M$3.11$3.1M18.2M
Sep 19, 2025Option exercise(X)41K$19.09$783K18.2M
Sep 19, 2025Other(J)41K$3.11$128K18.2M
Sep 19, 2025Option exercise(X)59K$17.81$1.1M18.2M
Sep 19, 2025Other(J)59K$3.11$183K18.2M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Sep 19, 2025Option exercise(X)1——0
Sep 19, 2025Option exercise(X)1——0
Sep 19, 2025Option exercise(X)1——0

Transaction Codes

X
Exercise of in-the-money derivative
J
Other acquisition / disposition

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001231919-25-000232) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML

Keep exploring

Connected pages for ROCKET PHARMACEUTICALS, INC.

Build

Ask your agent about RCKT insider filings

This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.

Get a key Compare plansForm 4 data
Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/filing/0001231919-25-000232"
Ask your agent
Use Arkolith to summarize insider buying and selling at ROCKET PHARMACEUTICALS, INC.
over the last 90 days and cite the filings.